Totally thoracoscopic left atrial occlusion concomitant to endoscopic atraumatic coronary artery bypass grafting

Piotr Suwalski1, Anna Witkowska1

  • 1Clinical Department of Cardiac Surgery, Central Clinical Hospital Ministry of Interior and Administration in Warsaw, Poland, 02-507 Woloska Street 137.

Insights

This study introduces a novel, minimally invasive procedure combining coronary artery bypass grafting and left atrial appendage occlusion. This approach aims to reduce stroke risk and bleeding complications in patients with atrial fibrillation and coronary artery disease.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Arrhythmology

Background:

  • Atrial fibrillation is a common arrhythmia linked to increased morbidity, mortality, and stroke risk.
  • Coronary artery disease frequently coexists with atrial fibrillation, complicating treatment strategies.
  • Antithrombotic therapy for stroke prevention in atrial fibrillation carries a significant bleeding risk, especially in elderly or frail patients.

Observation:

  • The left atrial appendage is a primary source of emboli in atrial fibrillation.
  • Left atrial appendage occlusion offers a potential alternative to long-term anticoagulation.
  • Simultaneous surgical procedures can improve patient outcomes and reduce overall treatment burden.

Findings:

  • This paper details the first reported simultaneous totally thoracoscopic 3D augmented coronary artery bypass grafting and left atrial appendage occlusion.
  • The described technique facilitates a combined approach to managing coronary artery disease and stroke risk in atrial fibrillation.
  • Minimally invasive thoracoscopic surgery offers advantages in reducing patient trauma and recovery time.

Implications:

  • This combined procedure may offer a solution for patients requiring both revascularization and stroke risk mitigation.
  • It presents a potentially safer alternative to dual or triple antithrombotic therapy in high-risk patients.
  • Further research is warranted to evaluate the long-term efficacy and safety of this combined approach.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.5K